fuzzy
Gene Signature
|
HG 1&3 patients
|
fuzzy
Gene Signatures
|
Histologic grade
|
---|
n
|
Hazard Ratio (95% CI)
|
p value logrank test
|
Hazard Ratio (95% CI)
|
p value logrank test
|
---|
f
MG A
| | | | | |
NKI2 training
|
113
|
2.136 (1.466 - 3.113)
|
<.001
|
1.5896 (1.135 - 2.213)
|
<0.0052
|
NKI2 validation all
|
163
|
1.989 (1.463 - 2.704)
|
<.001
|
1.694 (1.294 - 2.218)
|
<.001
|
f
MG B
| | | | | |
KJX64/KJ125 training
|
99
|
1.923 (1.342 - 2.754)
|
<.001
|
1.546 (1.075 - 2.223)
|
<0.0184
|
Transbig
|
113
|
1.435 (1.005 - 2.051)
|
<0.0426
|
1.062 (0.792 - 1.426)
|
=0.0541
|
Stockholm
|
89
|
2.711 (1.313 - 5.595)
|
<0.00158
|
2.104 (1.28 - 3.459)
|
<0.0103
|
Pool 1
|
272
|
1.59 (1.25 to 2,02)
|
<0.0001
|
1.55 (1.20 to 2.00)
|
<0.001
|
f
MG C
| | | | | |
Uppsala training
|
123
|
1.484 (1.091 - 2.017)
|
<0.0103
|
1.773 (1.306 - 2.408)
|
<.001
|
Stockholm
|
89
|
4.134 (1.518 - 11.258)
|
<.001
|
2.104 (1.28 - 3.459)
|
<0.0103
|
f
MG D
| | | | | |
Transbig Training
|
113
|
1.28 (0.852 - 1.923)
|
=0.23
|
1.062 (0.792 - 1.426)
|
=0.0541
|
KJX64/KJ125
|
122
|
1.591 (1.157 - 2.186)
|
<0.00312
|
1.518 (1.11 - 2.077)
|
<0.00725
|
Stockholm
|
89
|
3.844 (1.412 - 10.469)
|
<.001
|
2.104 (1.28 - 3.459)
|
<0.0103
|
Pool 2
|
281
|
1.65 (1.31 to 2,07) supp KJX
|
<0.00001
|
1.66 (1.32 to 2.09)
|
<0.00001
|
- Pool 1: Uppsala + Transbig + Stockholm.
- Pool 2: KJX64/KJ125 + Uppsala + Stockholm.